Advertisement
Biological Psychiatry
Advanced SearchSave search
Full length article| Volume 40, ISSUE 9, P913-917, November 01, 1996

Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients

  • Henk Pols
    Correspondence
    Address reprint requests to Henk Pols, M.D., Department of Psychiatry & Neuropsychology, Section Clinical and Biological Psychiatry, State University of Limburg, P.O. Box 616, 6200MD, Maastricht, The Netherlands.
    Affiliations
    Department of Psychiatry & Neuropsychology, Section Clinical and Biological Psychiatry, State University of Limburg, Maastricht, The Netherlands
    Search for articles by this author
  • Kees Verburg
    Affiliations
    Department of Psychiatry & Neuropsychology, Section Clinical and Biological Psychiatry, State University of Limburg, Maastricht, The Netherlands
    Search for articles by this author
  • Roos Hauzer
    Affiliations
    Department of Psychiatry & Neuropsychology, Section Clinical and Biological Psychiatry, State University of Limburg, Maastricht, The Netherlands
    Search for articles by this author
  • Jaap Meijer
    Affiliations
    Department of Psychiatry & Neuropsychology, Section Clinical and Biological Psychiatry, State University of Limburg, Maastricht, The Netherlands
    Search for articles by this author
  • Eric Griez
    Affiliations
    Department of Psychiatry & Neuropsychology, Section Clinical and Biological Psychiatry, State University of Limburg, Maastricht, The Netherlands
    Search for articles by this author
DOI:https://doi.org/10.1016/0006-3223(95)00494-7
Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients
Previous ArticleCytokine production in obsessive-compulsive disorder
Next ArticleSocial isolation in animal models of relevance to neuropsychiatric disorders
      This paper is only available as a PDF. To read, Please Download here.
      A group of 20 patients who met the DSM-III-R criteria for panic disorder with or without agoraphobia underwent a 35% carbon dioxide (CO2) challenge after either 1 mg alprazolam or placebo in a double-blind, randomized, cross-over design. Despite the anxiolytic potential of alprazolam, it produced no significant effects on CO2-induced anxiety and panic symptomatology when compared to placebo.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • American Psychiatric Association
        3rd ed rev. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, New York1987
        • Ballenger J
        • Burrows G
        • Dupont R
        • Lesser I
        • Noyes R
        • Peckhold J
        • Rifkin A
        • Swinson R
        Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial.
        Arch Gen Psychiatry. 1988; 45: 413-422
        • Battaglia M
        • Perna G
        The 35% CO2 challenge in panic disorder: Optimization by receiver operating characteristic (ROC) analysis.
        J Psychiatry Res. 1995; 29: 11-119
        • Beckett A
        • Fishman SM
        • Rosenbaum JF
        Clonazepam blockade of spontaneous and CO2 inhalation-provoked panic in a patient with panic disorder.
        J Clin Psychiatry. 1986; 47: 475-476
        • Biggio G
        • Cuccheddu T
        • Floris S
        • Sanna E
        • Barbaccia M
        • Roscetti G
        • Serra M
        • Concas A
        Stress and GABAergic transmission in the rat brain: The effect of carbon dioxide inhalation.
        in: Hamon M Ollat H Thiébot M Anxiety: Neurobiology, Clinic and Therapeutic Perspectives. Vol 232. Colloque INSERM/John Libbey Eurotext Ltd, Washington DC1993: 53-64
        • Fishman SM
        • Carr DB
        • Beckett A
        • Rosenbaum JF
        Hypercapneic ventilatory response in patients with panic disorder before and after alprazolam treatment and in pre- and postmenstrual women.
        J Psychiatry Res. 1994; 28: 165-170
        • Gorman JM
        • Askananzi J
        • Liebowitz MR
        • Fyer AJ
        • Stein J
        • Kinney JM
        • Klein DF
        Response to hyperventilation in a group of patients with panic disorder.
        Am J Psychiatry. 1984; 43: 1067-1071
        • Griez E
        • Lousberg H
        • van den Hout MA
        • van der Molen GM
        CO2 vulnerability in panic disorder.
        Psychiatry Res. 1987; 20: 87-95
        • Griez E
        • de Loof C
        • Pols H
        • Zandbergen J
        • Lousberg H
        Specific sensitivity of patients with panic attacks to carbon dioxide inhalation.
        Psychiatry Res. 1990; 31: 193-199
        • Griez E
        • Zandbergen J
        • Pols H
        • de Loof C
        Response to 35% CO2 as a marker of panic in severe anxiety.
        Am J Psychiatry. 1990; 147: 796-797
        • Papp LA
        • Klein DF
        • Martinez J
        • Schneier F
        • Cole R
        • Liebowitz MR
        • Hollander E
        • Fyer AJ
        • Jordan F
        • Gorman JM
        Diagnostic and substance specificity of carbon dioxide-induced panic.
        Am J Psychiatry. 1993; 150: 250-257
        • Perna G
        • Battaglia M
        • Garberi A
        • Arancio C
        • Bertani A
        • Bellodi L
        Carbon dioxide/oxygen challenge test in panic disorder.
        Psychiatry Res. 1994; 52: 159-171
        • Perna G
        • Cocchi S
        • Bertani A
        • Arancio C
        • Bellodi L
        Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: A single-blind, random, placebocontrolled study.
        J Clin Psychopharmacol. 1994; 14: 414-418
        • Sanderson WC
        • Wetzler S
        • Asnis GM
        Alprazolam blockade of CO2-provoked panic in patients with panic disorder.
        Am J Psychiatry. 1994; 151: 1220-1223
        • Sanna E
        • Cuccheddu T
        • Serra M
        • Concas A
        • Biggio G
        Carbon dioxide reduces the function of GABAA receptors in the rat brain.
        Eur J Pharmacology. 1992; 216: 457-458
        • Woods SW
        • Charney DS
        • Loke WK
        • Goodman GR
        • Redmond Jr, DE
        • Heninger GR
        Carbon dioxide sensitivity in panic anxiety.
        Arch Gen Psychiatry. 1986; 43: 900-909
        • Woods SW
        • Charney DS
        • Delgado PL
        • Heninger GR
        The effect of long-term imipramine treatment on carbon dioxideinduced anxiety in panic disorder patients.
        J Clin Psychiatry. 1990; 51: 505-507

      Article Info

      Publication History

      Received in revised form: July 31, 1995
      Received: January 6, 1995

      Identification

      DOI: https://doi.org/10.1016/0006-3223(95)00494-7

      Copyright

      © 1996 Society of Biological Psychiatry. Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX